Patent US5267974A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5267974A Expired / Lapsed US ⏱️ 0.0 years remaining

Hypodermic syringe with foam sponge reservoir

Assignee: Individual
•
Filing: 1992-06-04
•
Granted: 1993-12-07
•
Expires: 2012-06-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A safely-disposable, one-use limited, sealingly-enveloped, injectant-saturated, elastic foam sponge, axially encompassing a hypodermic cannula, depressably slidable there-thru for simultaneous, subcutaneous tissue injection.

Inventors

  • 👤 William S. Lambert

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 18:46
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/178; A61M5/28; A61M5/281; A61M5/282; A61M5/001; A61M5/31; A61M5/32; A61M5/3205; A61M5/321; A61M5/3243; A61M5/3257

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 143 words
A dosage-dimensionable, composite, safely disposable, self-injectable hypodermic syringe, comprising: a minimally thin-skinned, hermetically sealable, resilient film-envelope, precisely formulated self-healingly, to effect a radially-contracting, transverse, liquid seal around the periphery of an axially penetratable cannula; a cylindrical, injectant-saturated, absorbingly open-celled, reconformably collapsible, elastic, semi-rigid foam sponge reservoir media, having opposing outermost and discharge endwalls, comprehensively enclosed by said film-envelope; and an axially penetratable cannula comprised of a needle body having a disc-butted end and a sharp-pointed end opposite one another, and a strategically placed side-vented discharge inlet perforation within the needle body, said cannula proportionally and centrically disposed internally of said foam sponge; whereby said syringe facilitates an outermost endwall to discharge endwall, wholly maximal, axial compression there in between, compelling said needle to slidably penetrate projectedly there through to immediate tissue implantation per resultant simultaneous, thru-needle conductive total discharge of the injectant content.
Claim 2
Dependent Claim 143 words
A dosage-dimensionable, composite, safely disposable, self-injectable hypodermic syringe, comprising: a minimally thin-skinned, hermetically sealable, resilient film-envelope, precisely formulated self-healingly, to effect a radially-contracting, transverse, liquid seal around the periphery of an axially penetratable cannula; a cylindrical, injectant-saturated, absorbingly open-celled, reconformably collapsible, elastic, semi-rigid foam sponge reservoir media, having opposing outermost and discharge endwalls, comprehensively enclosed by said film-envelope; and an axially penetratable cannula comprised of a needle body having a disc-butted end and a sharp-pointed end opposite one another, and a strategically placed side-vented discharge inlet perforation within the needle body, said cannula proportionally and centrically disposed internally of said foam sponge; whereby said syringe facilitates an outermost endwall to discharge endwall, wholly maximal, axial compression there in between, compelling said needle to slidably penetrate projectedly there through to immediate tissue implantation per resultant simultaneous, thru-needle conductive total discharge of the injectant content.
Claim 3
Dependent Claim 33 words
The invention of claim 1 further comprising a snugly-constrictive finger ring having opposing ends which are fused to the periphery of the outermost endwall surface to facilitate digitally-engaged manipulation of the instant device.
Claim 4
Dependent Claim 43 words
The invention of claim 1 further comprising an antiseptic-impregnated, mucilaginous media contactively adhered to the surface of the discharge endwall to topically disseminate said antiseptic upon semi-adherable, epidermally contactive exposure, and having a stripable evaporation preventive cover film seal overlaying said mucilaginous media.

References Cited (Backward Citations)

US2403074A Cited
US2673561A Cited
US2696212A Cited
US2792835A Cited
US2769443A Cited
US2944549A Cited
US3094988A Cited
US4392859A Cited
US4666436A Cited
US4775363A Cited
US4795432A Cited
US4883068A Cited
US4919652A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-12-06 1997-06-07 1997-12-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-12-06 2001-06-07 2001-12-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-12-06 2005-06-07 2005-12-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag